Ayata has announced the availability of a new collaborative article that highlights the important role analytics will play in the healthcare industry’s future. This article explores the migration of the U.S. healthcare industry from a largely fee-for service, volume-based system to a fee-for-outcome, value-based system that will require analytics to make the new model a reality. This article captures perspectives from providers, payers, pharmaceuticals, and vendors – and offers views on how the healthcare industry needs to embrace analytics to improve efficiency, access and outcomes while reducing costs.
Analytics Magazine developed the article in collaboration with Ayata, Seton Family of Hospitals, Integrated Care Collaboration (ICC), Novartis, Robert Bosch Healthcare, and Kaiser Permanente’s Innovation and Advanced Technology Group.
Ayata (ayata.com) is the leader in Prescriptive Analytics® – the science of automatically synthesizing big data, mathematical sciences, business rules, and machine learning to make smarter decisions about future outcomes of business processes. Ayata’s enterprise customers use Prescriptive Analytics software to predict future outcomes of their critical business processes, prescribe decision options, and understand the impact of each decision option. Ayata’s technology is adaptive and thus can continuously facilitate accurate decision-making. Ayata is headquartered in Austin, Texas.